Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers

BACKGROUND: Achievement of low-density lipoprotein cholesterol (LDL-C) goal is the most important for the patients with atherosclerotic cardiovascular diseases (ASCVD) who received lipid-lowering therapy. It is unclear that whether combination of ezetimibe with statin is superior to double-dose of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Na-Qiong, Guo, Yuan-Lin, Zhu, Cheng-Gang, Gao, Ying, Zhao, Xi, Sun, Di, Sun, Jing, Xu, Rui-Xia, Liu, Geng, Dong, Qian, Li, Jian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260646/
https://www.ncbi.nlm.nih.gov/pubmed/30470229
http://dx.doi.org/10.1186/s12944-018-0909-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260646/
https://www.ncbi.nlm.nih.gov/pubmed/30470229
http://dx.doi.org/10.1186/s12944-018-0909-z

Ejemplares similares